Skip to content
Subscriber Only
Business
Prognosis

Biovac Plans to Become a Vaccine Maker for Underserved Africa

  • South African company to make Pfizer’s pneumococcal shots
  • Pandemic highlights Africa’s reliance on imported vaccines
The coronavirus outbreak has highlighted Africa’s reliance on imported vaccines.

The coronavirus outbreak has highlighted Africa’s reliance on imported vaccines.

Photographer: Tafadzwa Ufumeli/Getty Images

The Biovac Institute, a South African vaccine company, is formulating expansion plans aimed at helping Africa become more self-sufficient when its comes to accessing the immunizing shots.

The coronavirus outbreak has highlighted the continent’s reliance on imported vaccines, with limited shot-making facilities only present in South Africa, Senegal and Egypt. Biovac, which is 47.5% state-owned, is in talks to produce a Covid-19 vaccine at its facilities, and Aspen Pharmacare Holdings Ltd. has agreed to make Covid-19 shots on behalf of Johnson & Johnson at a facility in the southern city of Port Elizabeth.